(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC) receiving immune checkpoint inhibitors, treatment with broad-spectrum antibiotics (ATBs) can reduce progression-free survival, according to research presented ...
Feb 17, 2017
0
0
(HealthDay)—For patients with Barrett's esophagus (BE), proton pump inhibitor (PPI) but not histamine-2 receptor antagonist (H2RA) use is associated with reduced risk of neoplastic progression, according to research published ...
Feb 15, 2017
0
0
New research has found a link between popular heartburn drugs and an increase in the risk of infectious gastroenteritis—an illness that results in 13.1 million lost days of work in Australia a year.
Jan 12, 2017
0
1
Children born to mothers who take heartburn medication during pregnancy may have a greater risk of developing asthma, research suggests.
Jan 9, 2017
0
7
(HealthDay)—People who take heartburn drugs such as Prilosec and Nexium may be at increased risk of two potentially serious gut infections, a new study suggests.
Jan 5, 2017
0
72
In a population-based study from Scotland, use of commonly-prescribed acid suppression medications such as proton pump inhibitors (PPIs) was linked with an increased risk of intestinal infections with C. difficile and Campylobacter ...
Jan 5, 2017
0
133
(HealthDay)—For patients beginning warfarin therapy, proton pump inhibitor (PPI) co-therapy is associated with reduced risk of upper gastrointestinal bleeding, according to a study published in the December issue of Gastroenterology.
Dec 23, 2016
0
0
Something as seemingly harmless as a heartburn pill could lead cancer patients to take a turn for the worse. A University of Alberta study published in journal JAMA Oncology discovered that proton pump inhibitors (PPIs), ...
Dec 16, 2016
0
2
The hip fracture risk factors are generally similar among those with and without Alzheimer's disease, according to a recent study from the University of Eastern Finland. However, the incidence of hip fracture is higher among ...
Dec 7, 2016
0
1
(HealthDay)—Thirty-seven percent of premature infants receive gastroesophageal reflux (GER) medications, with more than three-quarters initiating medication use after discharge from the neonatal intensive care unit (NICU), ...
Nov 30, 2016
0
71
